ZEB1 and breast cancer: Furthermore, a dose-dependent inhibition of ZEB1 protein levels was confirmed in MDA-MB-231 and SUM-159 breast cancer cells in response to treatment with 50–150 μM biochanin A (Supplementary Fig. S1b).